Value Bridge — CEDARS-SINAI MEDICAL CENTER
Current $-217M → Target $-130M (+$86.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-216.5M
Current EBITDA
$-129.8M
Target EBITDA
+$86.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$19.6M
Payer Mix Optimization
$47.1M
Cost to Collect Reduction
$15.7M
Clean Claim Improvement
$11.8M
Volume & Rate Growth
$78.5M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-217M to $-130M. The highest-impact lever is Volume & Rate Growth at $31.4M probability-weighted.
IC talking point: "We see $87M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $954M in equity value creation."